Medulla Pharmaceuticals Private Limited
About Medulla Pharmaceuticals Private Limited
Data last updated:
Medulla Pharmaceuticals Private Limited is a private limited company based in Cuttack Sadar, Odisha, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 22 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24230OR2016PTC019823. Its GSTIN is 21AAKCM1436B1Z4 (Odisha).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Shyam Sundar Pandia (Managing Director) and Anjali Pandia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Cuttack Sadar, Odisha.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.04 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹6.93 Lakh (net margin 2.3%) and EBITDA of ₹12.72 Lakh (EBITDA margin 4.2%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 27% over five years.
As per MCA filings, the company has open charges of ₹7 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 3/C/1321, Sector – 11, Cuttack Sadar, Odisha, India – 753014
- IndustryHealthcare, Preventive Health Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medulla Pharmaceuticals Private Limited
The main business activity of Medulla Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medulla Pharmaceuticals Private Limited FY 2025 filings available
Medulla Pharmaceuticals Private Limited reported revenue of ₹3.04 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Medulla Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 7% growth in the latest year. EBITDA fell 50% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Medulla Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹12.72 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.93 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Medulla Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medulla Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Medulla Pharmaceuticals Private Limited
Medulla Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Pharma Retail and Distribution, Pharmaceuticals, Preventive Healthcare Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sneha Super Specialty Hospitals Private Limited | ₹3.05 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Tirupati, Andhra Pradesh, India |
| Satya Medical Services Private Limited | ₹3.05 Cr (FY 2025) | •••• | •••• | 48.0% | •••• | New Delhi, Delhi, India |
| Aldan Healthcare Private Limited | ₹3.05 Cr (FY 2025) | •••• | •••• | -17.0% | •••• | Mumbai, Maharashtra, India |
| Phytoscience Trendmakers Private Limited | ₹3.04 Cr (FY 2020) | •••• | •••• | -23.0% | •••• | Pune, Maharashtra, India |
| Um Pharma Private Limited | ₹3.04 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Pune, Maharashtra, India |
| Medulla Pharmaceuticals Private Limited this company | ₹3.04 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Cuttack Sadar, Odisha, India |
| Pinnacle Medicare Private Limited | ₹3.03 Cr (FY 2024) | •••• | •••• | -20.0% | •••• | Delhi, India |
| Sam Healthcare & Nursing Home Private Limited | ₹3.03 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Patna, Bihar, India |
| Vrundavan Shalby Hospitals Limited | ₹3.03 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Goa, India |
| Rainbow Emergency & Trauma Hospital Private Limited | ₹3.03 Cr (FY 2025) | •••• | •••• | -14.0% | •••• | Patna, Bihar, India |
| Iriska Pharmaceuticals Private Limited | ₹3.03 Cr (FY 2025) | •••• | •••• | 52.0% | •••• | Hapur, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Medulla Pharmaceuticals by revenue in the Healthcare industry (Pharma Retail and Distribution, Pharmaceuticals, Preventive Healthcare Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Medulla Pharmaceuticals Private Limited
Medulla Pharmaceuticals Private Limited is audited by ASSA & ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ASSA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Medulla Pharmaceuticals Private Limited
Medulla Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anjali Pandia | Director | 11 Apr 2024 | 2 Years 6 Months | Current |
| Shyam Sundar Pandia | Managing Director | 22 Jan 2016 | 10 Years 8 Months | Current |
Ownership and Shareholding of Medulla Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medulla Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jan 2020 | Others | ₹7 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Medulla Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Medulla Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medulla Pharmaceuticals Private Limited
Medulla Pharmaceuticals Private Limited has 6 board changes on record since 2016: 2 appointments and 4 cessations. The latest: Anjali Pandia was appointed as Director on 11 Apr 2024.
Credit Ratings, Litigation & Regulatory Alerts for Medulla Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medulla Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medulla Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medulla Pharmaceuticals Private Limited
Medulla Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAKCM1436B1Z4 | Odisha | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medulla Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medulla Pharmaceuticals Private Limited
Medulla Pharmaceuticals is an active private limited company based in Cuttack Sadar, Odisha, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 22 January 2016 (10+ years old) and is registered under CIN U24230OR2016PTC019823.
Medulla Pharmaceuticals reported revenue of ₹3.04 Cr for FY 2025 (up 7% YoY).
Medulla Pharmaceuticals has 2 current directors:
- Shyam Sundar Pandia - Managing Director
- Anjali Pandia - Director
Medulla Pharmaceuticals reported a net profit of ₹6.93 Lakh (net margin 2.3%) and EBITDA of ₹12.72 Lakh (EBITDA margin 4.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Medulla Pharmaceuticals is 33% over three years and 27% over five years. In the latest year (FY 2025) revenue rose 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Medulla Pharmaceuticals is 21AAKCM1436B1Z4, registered in Odisha.
The CIN (Corporate Identification Number) of Medulla Pharmaceuticals is U24230OR2016PTC019823. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medulla Pharmaceuticals was incorporated on 22 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Medulla Pharmaceuticals by revenue are Sneha Super Specialty Hospitals Private Limited, Satya Medical Services Private Limited, Aldan Healthcare Private Limited, Phytoscience Trendmakers Private Limited, Um Pharma Private Limited and 5 more, all in the Healthcare industry (Pharma Retail and Distribution, Pharmaceuticals, Preventive Healthcare Services).
Anjali Pandia was appointed as Director on 11 Apr 2024. Darpa Narayan Singh ceased to be Director on 29 Mar 2024. Shyam Sundar Pandia ceased to be Director on 12 Dec 2018. Medulla Pharmaceuticals has 6 board changes on record in total.
The registered office of Medulla Pharmaceuticals is at Plot No. 3C1321, Sector – 11, Cuttack Sadar, Odisha, India – 753014.